Clinical Trial

Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.

Study acronym: KANNON-2
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
Efficacy and safety evaluation of PLB1004 in patients with locally advanced/metastatic non-squamous NSCLCharboring EGFR exon 20 insertion.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-20; most recent amendment 2026-04-21.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-06-10
Trial Details
NCT Number NCT06281964
Lead Sponsor Avistone Biotechnology Co., Ltd.
Conditions Non-Small-Cell Lung Cancer
Enrollment 327 participants
Start Date 2023-12-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23